CORZ Core Scientific, Inc./tx
Q3 2025 10-Q
Core Scientific, Inc./tx (CORZ) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 24, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • Newly added merger risk: $270M termination fee if Merger Agreement terminated due to Board recommendation change or other specified conditions
- • Updated regulatory risk: Merger completion dependent on Nasdaq approval of CoreWeave Class A stock listing and no injunctive legal orders
Quarterly Financial SummaryXBRL
Revenue
$81M
▼ -14.9% YoY▲ +3.1% QoQ
Net Income
-$147M
▲ +67.8% YoY▲ +84.3% QoQ
Gross Margin
4.8%
▼ -158bp QoQ
Operating Margin
-70.8%
▼ -2758bp YoY▼ -3738bp QoQ
Net Margin
-180.8%
▲ +29661bp YoY▲ +101060bp QoQ
ROE
13.0%
Total Assets
$2.3B
EPS (Diluted)
$-1.27
▼ -51.2% YoY▲ +13.0% QoQ
Operating Cash Flow
$132M
▲ +2206.7% YoY▲ +287.6% QoQ
Source: XBRL data from Core Scientific, Inc./tx Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Core Scientific, Inc./tx
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.